Company Info
Phone(858) 558-2871
Year Established
2014
Ticker
ACAD
Exchange
NASDAQ
Contacts
Catherine Owen AdamsCEO
Konstantina Katcheves
CBO
Mark Schneyer
CFO
Thomas Garner
CCO
Jennifer J. Rhodes
CLO
Elizabeth H. Z. Thompson, Ph.D.
Executive VP, R&D
Company Description
ACADIA, formerly Receptor Technologies, is a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system disorders.